Condition
Antidepressants
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
Early P 1 (1)
Trial Status
Completed4
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06337539Completed
Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants
NCT05191277Not ApplicableCompleted
Disentangling Pharmacological and Expectation Effects in Antidepressant Discontinuation
NCT06796946Early Phase 1Not Yet Recruiting
Deprescription of Antidepressants in Primary Care (DAPriCare)
NCT05051995Not ApplicableCompleted
Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation Symptoms
NCT03361514Not ApplicableCompletedPrimary
Discontinuation of Antidepressant Medication in Primary Care.
Showing all 5 trials